Annovis Bio Inc

ANVSNYSE · USD
0.75USD-0.18 (-19.02%)
152

Annovis Bio Inc (ANVS) Option Chain

Read more

Tracking the ANVS option chain helps you see every strike and expiry on Annovis Bio Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ANVS options activity at a glance. Use our scanner to monitor the ANVS option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ANVS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ANVS options are being actively traded, and where they are not.

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
100.007212240.250.250.300.700.50-46.24—1.000.001.00000.00
100.005000.550.00—0.551.00+7.53—0.450.250.20000.00
100.00002.000.00—2.001.50+61.29—1.100.750.35000.00
100.00002.000.00—2.002.00+115.05—2.301.251.05000.00
100.00002.000.00—2.002.50+168.82—4.001.752.25000.00

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank85.32% High
  • Market cap (M$)40
  • 52 weeks high-83.09%
  • 52 weeks low50.00%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$10.50
    1300.00% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-13
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.79
  • EPS growth next 5 years-2.67%

As of Nov 13, 2026